CenterPoint Energy, Inc. (CNP) Stock Forecast
Data as of May 2, 2026Utilities · Current price $43.48 (-0.41%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 16, 2026 | Julien Dumoulin-Smith | Jefferies | $49.00 | +12.7% |
| Jan 20, 2026 | Shahriar Pourreza | Wells Fargo | $47.00 | +8.1% |
| Dec 16, 2025 | David Arcaro | Morgan Stanley | $36.00 | -17.2% |
| Dec 12, 2025 | Sophie Karp | KeyBanc | $41.00 | -5.7% |
| Oct 27, 2025 | Shahriar Pourreza | Wells Fargo | $44.00 | +1.2% |
| Oct 2, 2025 | James Thalacker | BMO Capital | $41.00 | -5.7% |
| Aug 21, 2025 | David Arcaro | Morgan Stanley | $38.00 | -12.6% |
| Jul 25, 2025 | Anthony Crowdell | Mizuho Securities | $39.00 | -10.3% |
| Apr 25, 2025 | Andrew Weisel | Scotiabank | $40.00 | -8.0% |
| Dec 3, 2024 | William Appicelli | UBS | $37.00 | -14.9% |
| Nov 27, 2024 | James Thalacker | BMO Capital | $34.00 | -21.8% |
| Oct 29, 2024 | Andrew Weisel | Scotiabank | $30.00 | -31.0% |
| Oct 14, 2024 | Nicholas Campanella | Barclays | $29.00 | -33.3% |
| Oct 1, 2024 | Andrew Weisel | Scotiabank | $28.00 | -35.6% |
| Sep 25, 2024 | David Arcaro | Morgan Stanley | $32.00 | -26.4% |
| Sep 16, 2024 | Ryan Levine | Citigroup | $34.00 | -21.8% |
| Sep 12, 2024 | Ross Fowler | Bank of America Securities | $29.00 | -33.3% |
| Aug 26, 2024 | James Thalacker | BMO Capital | $28.00 | -35.6% |
| Jul 22, 2024 | Sophie Karp | KeyBanc | $31.00 | -28.7% |
| Jun 26, 2024 | James Thalacker | BMO Capital | $33.00 | -24.1% |
Top Analysts Covering CNP
CNP vs Sector & Market
| Metric | CNP | Utilities Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.40 | 2.62 | 2.41 |
| Analyst Count | 10 | 9 | 18 |
| Target Upside | +0.1% | +49.9% | +14.9% |
| P/E Ratio | 26.67 | -3.47 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $9.71B | $9.90B | $10.18B | 5 |
| 2027-12-31 | $10.06B | $10.37B | $10.61B | 9 |
| 2028-12-31 | $10.76B | $10.86B | $10.96B | 10 |
| 2029-03-31 | $3.07B | $3.11B | $3.18B | 1 |
| 2029-06-30 | $3.08B | $3.12B | $3.19B | 1 |
| 2029-09-30 | $3.09B | $3.13B | $3.20B | 1 |
| 2029-12-31 | $3.10B | $3.15B | $3.22B | 1 |
| 2030-03-31 | $3.12B | $3.16B | $3.23B | 1 |
| 2030-06-30 | $3.13B | $3.17B | $3.24B | 1 |
| 2030-09-30 | $3.14B | $3.18B | $3.25B | 1 |
| 2030-12-31 | $3.15B | $3.19B | $3.26B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.90 | $1.91 | $1.92 | 11 |
| 2027-12-31 | $2.02 | $2.08 | $2.10 | 11 |
| 2028-12-31 | $2.22 | $2.26 | $2.36 | 5 |
| 2029-03-31 | $0.81 | $0.82 | $0.85 | 4 |
| 2029-06-30 | $0.49 | $0.50 | $0.52 | 2 |
| 2029-09-30 | $0.55 | $0.56 | $0.58 | 2 |
| 2029-12-31 | $0.55 | $0.56 | $0.58 | 2 |
| 2030-03-31 | $0.88 | $0.89 | $0.92 | 2 |
| 2030-06-30 | $0.53 | $0.54 | $0.56 | 2 |
| 2030-09-30 | $0.60 | $0.61 | $0.63 | 5 |
| 2030-12-31 | $0.60 | $0.61 | $0.63 | 5 |
Frequently Asked Questions
What is the analyst consensus for CNP?
The consensus among 10 analysts covering CenterPoint Energy, Inc. (CNP) is Buy with an average price target of $41.75.
What is the highest price target for CNP?
The highest price target for CNP is $49.00, set by Julien Dumoulin-Smith at Jefferies on 2026-04-16.
What is the lowest price target for CNP?
The lowest price target for CNP is $28.00, set by James Thalacker at BMO Capital on 2024-08-26.
How many analysts cover CNP?
10 analysts have issued ratings for CenterPoint Energy, Inc. in the past 12 months.
Is CNP a buy or sell right now?
Based on 10 analyst ratings, CNP has a consensus rating of Buy (2.40/5) with a +0.1% upside to the consensus target of $41.75.
What are the earnings estimates for CNP?
Analysts estimate CNP will report EPS of $1.91 for the period ending 2026-12-31, with revenue estimated at $9.90B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.